Загрузка...
Lenalidomide as maintenance treatment for patients with multiple myeloma after autologous stem cell transplantation: A pharmaco‐economic assessment
OBJECTIVE: Autologous stem cell transplantation (ASCT) has improved progression‐free survival (PFS) and overall survival in eligible patients with newly diagnosed multiple myeloma (NDMM); however, relapse occurs. Maintenance therapy with lenalidomide (Len‐Mt) extends survival and delays relapse and...
Сохранить в:
| Опубликовано в: : | Eur J Haematol |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley and Sons Inc.
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7590122/ https://ncbi.nlm.nih.gov/pubmed/32705720 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ejh.13497 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|